# A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Older Adults

> **NCT07885956** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Pfizer** · enrollment: 750 (estimated)

## Conditions studied

- Respiratory Syncytial Virus (RSV)

## Interventions

- **BIOLOGICAL:** RSVpreF (Regimen A)
- **BIOLOGICAL:** RSVpreF (Regimen B)

## Key facts

- **NCT ID:** NCT07885956
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-29
- **Primary completion:** 2029-02-07
- **Final completion:** 2029-02-07
- **Target enrollment:** 750 (ESTIMATED)
- **Last updated:** 2026-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07885956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07885956, "A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Older Adults". Retrieved via MORVS 2026-11-22 from https://api.morvs.ai/clinical/NCT07885956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
